<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Emilia sonchifolia (L.) DC (Compositae), an herbaceous plant found in Taiwan and India, is used as folk medicine </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical applications include <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatism</z:e>, cough, cuts <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:e sem="disease" ids="C0013369" disease_type="Disease or Syndrome" abbrv="">dysentery</z:e>, <z:chebi fb="29" ids="35480">analgesic</z:chebi>, and antibacteria </plain></SENT>
<SENT sid="2" pm="."><plain>The activities of Emilia sonchifolia extract (ESE) on <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> have not been fully investigated </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of this study explored the induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and its molecular mechanisms in ESE-treated HCT 116 human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>The methanolic ESE was characterized, and Î³-<z:chebi fb="0" ids="5768">humulene</z:chebi> was formed as the major constituent (63.86%) </plain></SENT>
<SENT sid="5" pm="."><plain>ESE induced cell growth inhibition in a concentration- and time-dependent response by <z:chebi fb="0" ids="53233">MTT</z:chebi> assay </plain></SENT>
<SENT sid="6" pm="."><plain>Apoptotic cells (DNA fragmentation, an apoptotic catachrestic) were found after ESE treatment by TUNEL assay and DNA gel electrophoresis </plain></SENT>
<SENT sid="7" pm="."><plain>Alternatively, ESE stimulated the activities of caspase-3, -8, and -9 and their specific caspase inhibitors protected against ESE-induced cytotoxicity </plain></SENT>
<SENT sid="8" pm="."><plain>ESE promoted the mitochondria-dependent and <z:hpo ids='HP_0011420'>death</z:hpo>-receptor-associated protein levels </plain></SENT>
<SENT sid="9" pm="."><plain>Also, ESE increased ROS production and upregulated the levels of ATM, p53, and Fas in HCT 116 cells </plain></SENT>
<SENT sid="10" pm="."><plain>Strikingly, p53 siRNA reversed ESE-<z:mp ids='MP_0010831'>reduced viability</z:mp> involved in p53-mediated ATM/Fas signaling in HCT 116 cells </plain></SENT>
<SENT sid="11" pm="."><plain>In summary, our result is the first report suggesting that ESE may be potentially efficacious in the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>